| Product NDC: | 0074-1658 |
| Proprietary Name: | Zemplar |
| Non Proprietary Name: | Paricalcitol |
| Active Ingredient(s): | 5 ug/mL & nbsp; Paricalcitol |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0074-1658 |
| Labeler Name: | Abbott Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020819 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980417 |
| Package NDC: | 0074-1658-05 |
| Package Description: | 25 VIAL, MULTI-DOSE in 1 TRAY (0074-1658-05) > 2 mL in 1 VIAL, MULTI-DOSE |
| NDC Code | 0074-1658-05 |
| Proprietary Name | Zemplar |
| Package Description | 25 VIAL, MULTI-DOSE in 1 TRAY (0074-1658-05) > 2 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0074-1658 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Paricalcitol |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19980417 |
| Marketing Category Name | NDA |
| Labeler Name | Abbott Laboratories |
| Substance Name | PARICALCITOL |
| Strength Number | 5 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Cholecalciferol [Chemical/Ingredient],Vitamin D3 Analog [EPC] |